SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.72+3.5%11:33 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nestegg who wrote (8709)2/14/1999 10:54:00 AM
From: Robert K.  Read Replies (2) of 17367
 
I will say this with caution.> Should rbpi21 prove to be of benefit, then
we may "perhaps" see the ushering in of a new era of medical theory and treatment. Also rbpi21 holds the "potential" to be perhaps the greatest off label drug ever. Lastly, odds will greatly increase that we will see an array of human based proteins from this company. Now I know many will fail to understand this, or that many will argue this. But that is my current opinion as I see it. I understand (as should you),
that I may be wrong. As such, do your own research, make your own opinions ,judgements, and investment decisions. Value all I say as worthless, always. All disclaimers always apply to all my notes.
Good luck and Godspeed to xoma..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext